MedTrace Logo

Erythema Toxicum Neonatorum in Newborns and the Development of Asthma

NCT00178152 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 334

Last updated 2011-05-12

No results posted yet for this study

Summary

Erythema Toxicum Neonatorum (ETN) is a common skin finding that affects healthy full-term babies. Several authors have commented on the possible relationship between ETN and the development of atopic conditions, such as atopic dermatitis or respiratory disease later in life. There is a paucity of research addressing this issue.

Conditions

  • Asthma
  • Erythema Toxicum Neonatorum

Sponsors & Collaborators

  • University of Rochester

    lead OTHER

Principal Investigators

  • Jill S Halterman, MD, MPH · University of Rochester

  • Ritu Pabby, MD · West Penn Allegheny Health System

Eligibility

Min Age
3 Years
Max Age
9 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-05-31
Primary Completion
2005-11-30
Completion
2005-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00178152 on ClinicalTrials.gov